REDpoint International, Inc
REDpoint’s patent pending and FDA cleared medical devices provide the most effective solution to a $1B globally recognized problem.
Over 300M domestic IVs are placed annually. If secured by tape, 92% of IV catheters fail to survive the expected 96 hrs. dwell time. IV adhesives cause skin reactions on 34% of patients. 70% of IV failures requiring restarts result from catheter movement. REDpoint's Stedline is adhesive free and prevents IV failures as it absorbs over 10 times the amount of pull on the IV lines as compared to all other leading commercial means of stabilization.